Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers

Drug Development and Industrial Pharmacy

Volumn 33, Issue 4, 2007, Pages 449-456

  Tang, Cui ^a,b   Yu, Jing ^a   Yin, Lichen ^a   Yin, Chunhua ^a   Pei, Yuanying ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Insulin; P glycoprotein; Paracellular pathway; Protein adsorption; Transport; Valia Chien chamber

Indexed keywords

INSULIN;

ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; DRUG TRANSPORT; DUODENUM; HUMAN; HUMAN CELL; ILEUM; JEJUNUM; MALE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DUODENUM; EPITHELIUM; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; HYPOGLYCEMIC AGENTS; ILEUM; INSULIN; INTESTINAL ABSORPTION; JEJUNUM; MALE; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34249289741     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601011231     Document Type: Article

References (46)

1. Agarwal, V., Nazzal, S., Reddy, I. K., & Khan, M. A. (2001). Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids. J. Pharm. Pharmcol., 53(8), 1131-1138.
2. Alachi, A., & Greenwood R. (1994). Human insulin absorption from the intestine in diabetic rats. Drug Dev. Ind. Pharm., 20(14), 2333-2339.
3. Asada, H., Douen, T., Waki, M., Adachi, S., Fujita, T., Yamamato, A., & Muranishi, S. (1995). Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. J. Pharm. Sci., 84(6), 682-687.
4. Bai, J. P. F., & Chang, L. L. (1996). Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats. J. Pharm. Pharmacol., 48(10), 1078-1082.
5. Banga, A. K., Katakam, M., & Mitra, R. (1995). Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int. J. Pharm., 116(2), 211-216.
6. Bendayan, M., Ziv, E., Ben, S. R., Bar, O. H., & Kidron, M. (1990). Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia, 33(4), 197-204.
7. Bendayan, M., Ziv, E., Gingra, D., Ben, S. R., Bar, O. H., & Kidron, M. (1994). Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia, 37(2), 119-126.
8. Bernkop-Schnurch, A., & Walker, G. (2001). Multifunctional matrices for oral peptide delivery. Crit. Rev. Ther. Drug Carr. Syst., 18(5), 459-501.
9. Berggren, S., Hoogstraate, J., Fagerholm, U., & Lennernäs, H. (2004). Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. Eur. J. Pharm. Sci., 21(4), 553-560.
10. Boisset, M., Botham, R. P., Haegele, K. D., Lenfant, B., & Pachot, J. (2000). Absorption of angiotensin [#x025A1]antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: Importance of drug ionization in the in vitro prediction of in vivo absorption. Eur. J. Pharm. Sci., 10(3), 215-224.
11. Bowen, W. R., Calvo, J. I., & Hernández, A. (1995). Steps of membrane blocking in flux decline during protein microfiltration. J. Membrane. Sci., 101(1-2), 153-165.
12. + co-transport system in the Caco-2 human colon carcinoma cell line. Biochem. J., 299, 253-260.
13. Chen, G. S., Kim, D. D., & Chien, Y. W. (1995). Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery. J. Contr. Rel., 34(2), 129-143.
14. Chien YW. (1996). Human insulin: Basic sciences to therapeutic uses. Drug Dev. Ind. Pharm., 22(8), 753-789.
15. Chun, I. K., & Chien, Y. W. (1993). Transmucosal delivery of methionine enkephalin. 1. Solution stability and kinetics of degradation in various rabbit mucosa extracts. J. Pharm. Sci., 82(4), 373-378.
16. Clinchy, B., Youssefi, M. R., & Håkansson, L. (2003). Differences in adsorption of serum proteins and production of IL-1ra by human monocytes incubated in different tissue culture microtiter plates. J. Immunol. Methods, 282(1-2), 53-61.
17. Daugherty, A. L., & Mrsny, R. J. (1999). Regulation of the intestinal epithelial paracellular barrier. Pharm. Sci. Technol. Today, 2(7), 281-287.
18. Delie, F., & Rubas, W. A. (1997). human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst., 14(3), 221-226.
19. Ghilzai N. M. K. (2003). New developments in insulin delivery. Drug Dev. Ind. Pharm., 29(3), 253-265.
20. Greenwood, R., & Al-Achi, A. (1997). Human insulin diffusion profile through a layer of Caco-2 cells. Drug Dev. Ind. Pharm., 23(2), 221-224.
21. Güell, C., & Davis, R. H. (1996). Membrane fouling during microfiltration of protein mixtures. J. Membrane. Sci., 119(2), 269-284.
22. Hoogstraate, A. J., Cullander, C., Nagelkerke, J. F., Senel, S., Verhoef, J. C., Junginger, H. E., & Boddé, H. E. (1994). Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm. Res., 11(1), 83-89.
23. Hunter, J., Hirst, B. H., & Simmons, N. L. (1993). P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res., 10(5), 743-749.
24. Hunter, J., Jepson, M. A., Tsuruo, T., & Simmons, N. L. (1993). Functional expression of P-glycoprotein in apical membrane of human intestinal Caco-2 cells. J. Biol. Chem., 268(20), 14991-14997.
25. Kim, D. D., & Chien, Y. W. (1996). Simultaneous skin permeation of dideoxynucleoside-type anti-HIV drugs. J. Contr. Rel., 40(1-2), 67-76.
26. Kontturi, K., & Vuoristo, M. (1996). Adsorption of globular proteins on polymeric microfiltration membranes. Desalination, 104(1-2), 99-105.
27. Krishna, G., Chen, K. J., Lin, C. C., & Nomeir, A. A. (1998). Estimation of permeability in Caco-2 monolayer of compounds that exhibit extensive nonspecific binding. Pharm. Res., 1(Suppl), S8.
28. Lennernäs, H., Nylander, S., & Ungell, A. L. (1997). Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharm. Res., 14(5), 667-671.
29. McRoberts, J. A., Aranda, R., Riley, N., & Kang, H. (1990). Insulin regulates the paracellular permeability of cultured intestinal epithelialcell monolayers. J. Clin. Invest., 85(4), 1127-1134.
30. Meaney, C. M., & O'Driscoll, C. M. (2000). A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt : fatty acid micellar systems using the Caco-2 cell culture model. Int. J. Pharm., 207(1-2), 21-30.
31. 2EDTA and sodium glycocholate on intestinal absorption of insulin. Biol. Pharm. Bull., 16(1), 68-72.
32. Saha, P., & Kou, J. H. (2002). Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. Eur. J. Pharm. Biopharm., 54(3), 319-324.
33. Sällberg, M., Blixt, M., Zhang, Z. X., & Ekstrand, J. (1995). Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide. Immunol. Lett., 46(1-2), 25-30.
34. Sayani, A. P., Kim, D. D, Frenkl, T. L., Chun, I. K., Wang, Y. J., & Chien, Y. W. (1994). Transmucosal delivery of enkephalins - comparative enhancing effects of dihydrofusidates and bile-salts. S.T.P. Pharm. Sci., 4(6), 470-476.
35. Schilling, R. J., & Mitra, A. K. (1990). Intestinal mucosal transport of insulin. Int. J. Pharm., 62(1), 53-62.
36. Sharma, R. C., Inoue, S., Roitelman, J., Schimke, R. T., & Simoni, R. D. (1992). Peptide transport by the multidrug resistance. J. Biol. Chem., 267(9), 5731-5734.
37. Sonne, O. (1985). Receptor-mediated degradation and internalization of insulin in the adenocarcinoma cell line HT-29 from human colon. Mol. Endocrinol., 39, 39-48.
38. Still, J. G. (2002). Development of oral insulin. Diabetes/Metab. Res. Rev., 18(Suppl), S29-S37.
39. Trier, J. S., & Madara, J. L. (1981). Physiology of the Gastrointestinal Tract, Raven Press: New York; 925-962.
40. Uchiyama, T., Sugiyama, T., Quan, Y. S., Kotani, A., Okada, N., Fujita, T., Muranishi, S., & Yamamoto, A. (1999). Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-β-D-maltopyranoside. J. Pharm. Pharmacol., 51(11), 1241-1250.
41. Ungell, A. L. (1993). Absorption from the gastrointestinal tract. In Current Status on Targeted Drug Delivery to the Gastrointestinal Tract. Capsugel Americas: Greenwood; 79-84.
42. Wadell, C., Björk, E., & Camber, O. (2003). Permeability of porcine nasal mucosa correlated with human nasal absorption. Eur. J. Pharm. Sci., 18(1), 47-53.
43. Wu, S. J., & Robinson, J. R. (1999). Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement. J. Contr. Rel., 62(1-2), 171-177.
44. Yamada, K., Murakami, M., Yamamoto, A., Takada, K., & Muranishi, S. (1992). Type hepatic uptake of liposomes in the rat. J. Pharm. Pharmacol., 44(9), 711-721.
45. Yee, S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man: face or myth. Pharm. Res., 14(6), 763-766.
46. Zornoza, T., Cano-Cebrián, M. J., Nalda-Molina, R., Guerri, C., Granero, L., & Polache, A. (2004). Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. Eur. J. Pharm. Sci., 22(5), 347-356.